Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2018-000217-21Phase 4Completed
Phase 4, open-label trial of cefuroxime in None (2 arms), sponsored by Aarhus University Hospital. Primary endpoints: Time above MIC in tissues, Tissue penetration ratios and 1 more. Started Feb 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2018-000217-21.